(6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate

C68H92N12O26+2 — CID 101338196

IUPAC(6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate
SMILESC[C@H](c1ccccc1)[C@@H]1/N=C(\[O-])C/[NH+]=C(\O)[C@H](CO)NC(=O)[C@@H]([C@H](O)[C@@H]2CNC(N)=[N+]2[C@@H]2O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]2O)NC(=O)[C@H]([C@H](O)[C@@H]2C[NH+]=C(N)N2)NC(=O)[C@@H](Cc2ccc(O[C@@H]3O[C@H](CO)[C@H](O[C@@H]4O[C@@H](CO)[C@H](OCc5ccc(OCc6ccccc6)cc5)[C@H](O)[C@@H]4O)C(O)[C@H]3O)cc2)NC1=O
InChIInChI=1S/C68H90N12O26/c1-30(34-10-6-3-7-11-34)45-61(97)74-37(20-31-12-18-36(19-13-31)102-65-56(94)53(91)58(43(27-84)105-65)106-66-55(93)52(90)57(42(26-83)104-66)101-29-33-14-16-35(17-15-33)100-28-32-8-4-2-5-9-32)60(96)78-46(48(86)38-21-72-67(69)76-38)63(99)79-47(62(98)75-39(24-81)59(95)71-23-44(85)77-45)49(87)40-22-73-68(70)80(40)64-54(92)51(89)50(88)41(25-82)103-64/h2-19,30,37-43,45-58,64-66,81-84,86-94H,20-29H2,1H3,(H11,69,70,71,72,73,74,75,76,77,78,79,85,95,96,97,98,99)/p+2/t30-,37-,38+,39+,40+,41+,42+,43-,45+,46+,47-,48-,49-,50+,51+,52-,53?,54+,55+,56-,57+,58+,64-,65-,66+/m1/s1
InChIKeyLNBJPMHICKXDIE-OEVKBZDZSA-P
MW1493.54 g/mol
LogP-13.86
Rot. Bonds23

About (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate

(6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate (PubChem CID 101338196) has the molecular formula C68H92N12O26+2 and a molecular weight of 1493.54 g/mol. Its IUPAC name is (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate.

Molecular Properties

Compound Name(6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate
PubChem CID101338196
Molecular FormulaC68H92N12O26+2
Molecular Weight1493.54 g/mol
Exact Mass1492.62
IUPAC Name(6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate
SMILESC[C@H](c1ccccc1)[C@@H]1/N=C(\[O-])C/[NH+]=C(\O)[C@H](CO)NC(=O)[C@@H]([C@H](O)[C@@H]2CNC(N)=[N+]2[C@@H]2O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]2O)NC(=O)[C@H]([C@H](O)[C@@H]2C[NH+]=C(N)N2)NC(=O)[C@@H](Cc2ccc(O[C@@H]3O[C@H](CO)[C@H](O[C@@H]4O[C@@H](CO)[C@H](OCc5ccc(OCc6ccccc6)cc5)[C@H](O)[C@@H]4O)C(O)[C@H]3O)cc2)NC1=O
InChIInChI=1S/C68H90N12O26/c1-30(34-10-6-3-7-11-34)45-61(97)74-37(20-31-12-18-36(19-13-31)102-65-56(94)53(91)58(43(27-84)105-65)106-66-55(93)52(90)57(42(26-83)104-66)101-29-33-14-16-35(17-15-33)100-28-32-8-4-2-5-9-32)60(96)78-46(48(86)38-21-72-67(69)76-38)63(99)79-47(62(98)75-39(24-81)59(95)71-23-44(85)77-45)49(87)40-22-73-68(70)80(40)64-54(92)51(89)50(88)41(25-82)103-64/h2-19,30,37-43,45-58,64-66,81-84,86-94H,20-29H2,1H3,(H11,69,70,71,72,73,74,75,76,77,78,79,85,95,96,97,98,99)/p+2/t30-,37-,38+,39+,40+,41+,42+,43-,45+,46+,47-,48-,49-,50+,51+,52-,53?,54+,55+,56-,57+,58+,64-,65-,66+/m1/s1
InChIKeyLNBJPMHICKXDIE-OEVKBZDZSA-P
XLogP-13.86
TPSA606.70 Ų
H-Bond Donors24
H-Bond Acceptors30
Rotatable Bonds23
Heavy Atoms106
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001493.54
LogP ≤ 5-13.86
H-Bond Donors ≤ 524
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate?
The IUPAC name of (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate (CID 101338196) is (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate.
What is the SMILES notation for (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate?
The canonical SMILES for (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate is C[C@H](c1ccccc1)[C@@H]1/N=C(\[O-])C/[NH+]=C(\O)[C@H](CO)NC(=O)[C@@H]([C@H](O)[C@@H]2CNC(N)=[N+]2[C@@H]2O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]2O)NC(=O)[C@H]([C@H](O)[C@@H]2C[NH+]=C(N)N2)NC(=O)[C@@H](Cc2ccc(O[C@@H]3O[C@H](CO)[C@H](O[C@@H]4O[C@@H](CO)[C@H](OCc5ccc(OCc6ccccc6)cc5)[C@H](O)[C@@H]4O)C(O)[C@H]3O)cc2)NC1=O.
What is the InChIKey of (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate?
The InChIKey is LNBJPMHICKXDIE-OEVKBZDZSA-P. The full InChI is InChI=1S/C68H90N12O26/c1-30(34-10-6-3-7-11-34)45-61(97)74-37(20-31-12-18-36(19-13-31)102-65-56(94)53(91)58(43(27-84)105-65)106-66-55(93)52(90)57(42(26-83)104-66)101-29-33-14-16-35(17-15-33)100-28-32-8-4-2-5-9-32)60(96)78-46(48(86)38-21-72-67(69)76-38)63(99)79-47(62(98)75-39(24-81)59(95)71-23-44(85)77-45)49(87)40-22-73-68(70)80(40)64-54(92)51(89)50(88)41(25-82)103-64/h2-19,30,37-43,45-58,64-66,81-84,86-94H,20-29H2,1H3,(H11,69,70,71,72,73,74,75,76,77,78,79,85,95,96,97,98,99)/p+2/t30-,37-,38+,39+,40+,41+,42+,43-,45+,46+,47-,48-,49-,50+,51+,52-,53?,54+,55+,56-,57+,58+,64-,65-,66+/m1/s1.
What are the key properties of (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate?
(6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate has a molecular weight of 1493.54 g/mol, XLogP of -13.86, 23 rotatable bonds, 24 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (6S,9R,12S,15R,18S)-12-[(R)-[(5S)-2-amino-4,5-dihydro-1H-imidazol-3-ium-5-yl]-hydroxymethyl]-9-[(S)-[(4S)-2-amino-3-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydro-1H-imidazol-3-ium-4-yl]-hydroxymethyl]-15-[[4-[(2S,3R,5R,6R)-5-[(2S,3S,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(4-phenylmethoxyphenyl)methoxy]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-5-hydroxy-6-(hydroxymethyl)-8,11,14,17-tetraoxo-18-[(1R)-1-phenylethyl]-1,7,10,13,16-pentaza-4-azoniacyclooctadeca-1,4-dien-2-olate is sourced from PubChem (CID 101338196), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).